Drug–Device Combination Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-2222 | Report Format : | Status : Upcoming |

Abstract

Drug–Device Combination Products Market: Overview

According to the U.S. Food and Drug Administration (FDA) and, a mixture product is distinct as, “Two or more part products packaged jointly in a sole package or as a unit and consist of drug and tool products, device and natural products, or biological and treatment products”. The increasing occurrence of chronic diseases amongst old population makes an inevitable requirement for efficient beneficial solutions. In light of such requirement, pharmaceutical and therapeutic tool industries now introducing drug–device combination products. Rising number of aged population, rising health care expenses along with the growing demand for point-of-care checkups are few of the fundamental features that encourage the development of the global drug-device combination market. Furthermore, dynamic interventions starting the NGO and government associations, along with the rising popularity for simple insidious surgeries, would finally drive the market development in the coming years. On the other hand, the high price of drugs, growing incidences of chronic illness, negative side effects linked with products and rising technological challenges to distributing drugs would act as a most important limitation for the market.

Drug–Device Combination Products Market: Growth Factors

The drug-device combination market is mainly motivated by exponential development in the manufacturing of highly developed drug deliverance plans coupled with the rising chronic illness burden, which is projected to be one of the most important features to hasten on the whole demand of the product in the market in the coming years. The exceptional acceptance rate of these products is also assumed to be a result of its inbuilt benefits over the conventional pharmacological options to bring therapeutics, which in turn persuades biotechnology, pharmaceutical and medicinal device companies to work further rising these products for successive commercialization.

Drug–Device Combination Products Market: Segmentation

The global drug–device combination products market is divided into application, product types, and geography. On the basis of product types, the market is classified as Inhalers, photosensitizers, wound care products, orthopedic products, infusion pumps, transdermal patches, drug eluting stents, and others. On the other hand, the application section is categorized as ophthalmic treatment, bone treatment, cardiovascular, non-cardiovascular, antimicrobial treatment, urological, cancer treatment, and diabetes treatment.

Drug–Device Combination Products Market: Regional Analysis

Geographically, the global market for drug–device combination products market has been divided into Rest of the World, Asia Pacific, Europe, and North America. Amongst these regions, in terms of returns, the drug–device combination market is dominated by North America. On the other hand, Asia Pacific is anticipated to see high development owing to the rising occurrence of cardiovascular diseases, diabetes, and obesity, building the most lucrative market in the future.

Drug–Device Combination Products Market: Competitive Players

The key players in the drug–device combination products market are W. L. Gore & Associates, Inc., Ethicon, Inc., Stryker Corporation, C.R. Bard, Inc., Pinnacle Biologics, Inc., CareFusion Corporation, Medline Industries, Inc., Covidien PLC, Mylan, Inc., Terumo Corporation, and Medtronic, Inc.

Global Drug–Device Combination Products Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports